Abstract
In Acute Myeloid Leukemia (AML) patients, a diversity of clinical and hematological parameters has been examined for possible value in calculating treatment response and survival. The study was conducted at National Institute of Bone Diseases, Karachi (NIBD), Sind, Pakistan, a tertiary care and teaching hospital, affiliated with Liaquat University of Medical and Health Sciences, Jamshoro. This study included 107 cases of de novo AML, both male and female patients of ages between 10-60 years were selected randomly. The clinical features included fever, weakness, loss of weight, vomiting, bleeding gums, liver and spleen enlargement, lymph node enlargement. The Laboratory investigations included CBC (Complete Blood Count) specifically heamoglobin percentage, total leucocyte count, platelet count and blast count: peripheral blood smears, bone marrow aspiration biopsy, trephine biopsy, cytochemistry (Myeloperoxidase Staining, Immunohistochemistry (CD markers)) and DNA extraction for genetic sequencing. Percentage, validity and cumulative index were calculated of all parameters. It was found that about 70% of AML patients were adults and FAB subtype M2 of acute myeloid leukemia was more prevalent than other subtypes, followed by AML, M1.
Highlights
Acute Myeloid Leukaemia (AML) is a collection of neoplastic blood disorders categorized by the proliferation and growth of immature hematopoietic cells in the bone marrow and blood
The high incidence of Acute Myeloid Leukemia (AML) is seen in adults, accounting for almost 80% of acute leukemia in adults and only 20% of acute leukaemias in children [1]
Acute Myeloid Leukemia (AML) is a varied selection of wide number of malignant neoplastic diseases that may be grouped on the basis of morphological, cytogenetic and with molecular and genetics criteria [6]
Summary
Acute Myeloid Leukaemia (AML) is a collection of neoplastic blood disorders categorized by the proliferation and growth of immature hematopoietic cells in the bone marrow and blood. Though AML is a quite uncommon disease, it only accounts for about 1.2% of cancer deaths in United States [2]. It is most commonly found acute leukemia in adults. Acute Myeloid Leukemia (AML) is a varied selection of wide number of malignant neoplastic diseases that may be grouped on the basis of morphological, cytogenetic and with molecular and genetics criteria [6]. The developing countries have greater burden of cancer including hematological malignancies due to population growth, aging and urbanization, changing dietary habits, better control of infections, and increasing tobacco consumption [9].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Hematology & Thromboembolic Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
